Scientists have evidence of a potential new biomarker to predict the aggressiveness of an often difficult-to-treat form of leukemia. They found that high levels of a particular enzyme in the blood are an indicator that chronic lymphocytic leukemia — the most common form of adult leukemia — will be aggressive and in need of immediate treatment.